A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma

NCT01076517 · clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Stanford University

Collaborators